- ‘Tis the Season: London florist creates $4.6 million Christmas wreath
- No tailgating allowed at Super Bowl XLVIII
- Pentagon to transport African troops to Central African Republic
- Chinese man fed up with his girlfriend’s shopping jumps to his death
- Ukraine leader to talk with protesters; Washington urges caution
- Pope Francis: A nun saved my life
- Israeli P.M. Netanyahu backs out of Mandela funeral
- Elian Gonzalez makes first trip outside Cuba since custody battle
- U.S., British intelligence agents enter online sci-fi world to spy on gamers
- Sarah Palin to host the outdoors show ‘Amazing America’
Independent voices from the The Washington Times Communities
Topic - Teva
The drug maker at the heart of a legal fight over access to emergency contraception said Friday it got the green light to offer its one-pill product to customers of all ages, who will not need a prescription or identification to purchase it.
The Food and Drug Administration said Tuesday it has approved selling a version of the morning-after contraceptive pill without a prescription to girls 15 years of age or older — down from the current 17-year-old age limit.